Publication | Closed Access

Identification and optimization of piperine analogues as neuroprotective agents for the treatment of Parkinson’s disease via the activation of Nrf2/keap1 pathway

Neurodegenerative DiseasesMedicinal ChemistryMedicineNeuroprotective AgentsPharmacological AgentNeuropharmacologyNrf2/keap1 PathwayPharmacotherapyNeurologyNeuroscienceNeuroprotectionPiperine AnaloguesPharmacologyDrug Discovery